On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Shares of Aurora Cannabis Inc. ACB advanced 4.58% to $6.62 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.50 ...

Aurora Cannabis (ACB) stock surges 27% in premarket after reporting strong Q3 fiscal 2025 results with record-breaking ...

EDMONTON, AB, February 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to ...

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

Consumer Cannabis Revenue: $9.9 million, down from $11.6 million last year. Aurora Cannabis Inc (NASDAQ:ACB) reported a record third quarter for medical cannabis revenue, net income, adjusted ...

Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $9.35. The company has a market capitalization of $330.81 million, a PE ratio of -7.93 and a beta of 1.85.

Aurora Cannabis (ACB) stock jumped 45% on strong earnings, driven by record medical cannabis sales. CGC, TLRY and CRON also gained as the sector rallied on Aurora’s performance and trade tariff ...

Aurora Cannabis’ short interest ratio sits at 5.2. This tells us that short interest on the stock is relatively high. It also suggests that the stock is experiencing more of a short cover rally ...

Aurora Cannabis (ACB) announces a strategic supply agreement with SNDL Inc, (SNDL) a Canadian licensed producer and vertically integrated ...